Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph phase_4
2
67%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Active, not recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 42 (66.7%)

Trials by Status

active_not_recruiting267%
recruiting133%

Recent Activity

3 active trials
Showing 3 of 3
active_not_recruitingphase_2

Bacterial Lysate In Preventing Asthma

NCT05064631
active_not_recruitingphase_4

OM 85 to Prevent Respiratory Infections in Older At Risk Patients

NCT07178002
recruitingphase_4

OM 85 to Prevent Respiratory Infections in Older At Risk Patients

NCT06655272

Clinical Trials (3)

Showing 3 of 3 trials
NCT05064631Phase 2

Bacterial Lysate In Preventing Asthma

Active Not Recruiting
NCT07178002Phase 4

OM 85 to Prevent Respiratory Infections in Older At Risk Patients

Active Not Recruiting
NCT06655272Phase 4

OM 85 to Prevent Respiratory Infections in Older At Risk Patients

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3